Author： Pfisterer J. du Bois A.
Publisher： Springer Publishing Company
ISSN： 0172-8113
Source： Der Pathologe, Vol.28, Iss.3, 2007-05, pp. : 222-228
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Caelyx® in der Therapie des fortgeschrittenen Ovarialkarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :
Access to resources
Recommend
Anthrazykline in der Therapie des Ovarialkarzinoms – Vergangenheit, Gegenwart und Zukunft
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :
Second-line-Therapie des Ovarialkarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. :
Therapie bei Progression und Rezidiv des Ovarialkarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :
Optimierung der primären Chemotherapie des fortgeschrittenen Ovarialkarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :